跳至主要内容
临床试验/NCT06458582
NCT06458582已完成不适用

High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Very Premature Infants: a Prospective Observational Study

Charles University, Czech Republic2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
试验地点
2
主要终点
HFNC slabilization

研究概览

简要总结

A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize very preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low SpO2.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
0 Minutes 至 2 Minutes(Child)
性别
All
接受健康志愿者

入选标准

  • Preterm infants born between 28+0 and 31+6 gestational weeks were enrolled in the study after obtaining parental informed consent.

排除标准

  • Infants with congenital malformations, previable rupture of membranes, and acute intrauterine hypoxia.

结局指标

主要结局

HFNC slabilization

时间窗: 10 minutes after delivery

Number of infants who were stabilized after birth on high flow nasal cannula exclusively without any other use of artificial external pressures.

次要结局

未报告次要终点

研究者

发起方
Charles University, Czech Republic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonáš Klára

Principal Investigator

Charles University, Czech Republic

研究点 (2)

Loading locations...

相似试验